Biointron is excited to announce our participation in World ADC USA 2025, a leading event dedicated to accelerating the development of antibody-drug conjugates (ADCs). Taking place in San Diego, CA, from November 3-6, 2025, this conference brings together industry experts, researchers, and innovators to explore the latest advancements in ADC technology, clinical progress, and manufacturing solutions.
Biointron is excited to announce our participation in World ADC Asia 2025, set to take place in Incheon, South Korea, from June 10-12, 2025. This premier event is dedicated to accelerating the development of antibody-drug conjugates (ADCs), uniting experts from across the biopharmaceutical industry to share insights, showcase innovations, and drive forward the future of targeted therapeutics.
Biointron is excited to announce our participation in the World ADC London 2025 Conference, set to take place March 3-6, 2025, in London, UK.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.


